3LY-32689-27152
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 313 / GA
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
-
2020-12-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Chills, Headache, Fatigue or tirednessAdult check-in
- 2020-12-29
- 2020-12-30
- 2021-01-06
- 2021-01-13
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Health check-in — day 7, dose 2Feeling: Good · Headache, Fatigue or tiredness, Nausea, VomitingAdult check-in
- 2021-01-28
- 2021-02-04
- 2021-02-11
-
2021-02-18
Survey response — day 35, dose 2MedDRA: Headache — Feeling: GoodFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-04-15
- 2021-07-15
- 2022-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech |
Free text
Release 4 — day 35, dose 2
Symptoms: Headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release